BioNexus Gene Lab Corp. (BGLC)
4.15
+0.01
(+0.24%)
USD |
NASDAQ |
Dec 16, 16:00
4.15
0.00 (0.00%)
After-Hours: 16:32
BioNexus Gene Lab Total Liabilities (Quarterly): 0.805M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Balchem Corp. | 363.17M |
| Innospec, Inc. | 496.50M |
| Alto Ingredients, Inc. | 166.07M |
| WD-40 Co. | 207.66M |
| General Enterprise Ventures, Inc. | 3.755M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.621M |
| Shareholders Equity (Quarterly) | 6.816M |
| Debt to Equity Ratio | 0.027 |
| Current Ratio | 8.299 |
| Net Debt Paydown Yield | 0.11% |